BROWSE

Related Scientist

kim,kyoungmi's photo.

kim,kyoungmi
유전체교정연구단
more info

ITEM VIEW & DOWNLOAD

Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration

DC Field Value Language
dc.contributor.authorKyoungmi Kim-
dc.contributor.authorSung Wook Park-
dc.contributor.authorJin Hyoung Kim-
dc.contributor.authorSeung Hwan Lee-
dc.contributor.authorDaesik Kim-
dc.contributor.authorTaeyoung Koo-
dc.contributor.authorKwang-eun Kim-
dc.contributor.authorJeong Hun Kim-
dc.contributor.authorJin-Soo Kim-
dc.date.available2017-05-19T01:12:13Z-
dc.date.created2017-04-24-
dc.date.issued2017-03-
dc.identifier.issn1088-9051-
dc.identifier.urihttps://pr.ibs.re.kr/handle/8788114/3428-
dc.description.abstractRNA-guided genome surgery using CRISPR-Cas9 nucleases has shown promise for the treatment of diverse genetic diseases. Yet, the potential of such nucleases for therapeutic applications in nongenetic diseases is largely unexplored. Here, we focus on age-related macular degeneration (AMD), a leading cause of blindness in adults, which is associated with retinal overexpression of, rather than mutations in, the VEGFA gene. Subretinal injection of preassembled, Vegfa gene-specific Cas9 ribonucleoproteins (RNPs) into the adult mouse eye gave rise to mutagenesis at the target site in the retinal pigment epithelium. Furthermore, Cas9 RNPs effectively reduced the area of laser-induced choroidal neovascularization (CNV) in a mouse model of AMD. Genome-wide profiling of Cas9 off-target effects via Digenome-seq showed that off-target mutations were rarely induced in the human genome. Because Cas9 RNPs can function immediately after in vivo delivery and are rapidly degraded by endogenous proteases, their activities are unlikely to be hampered by antibody- and cell-mediated adaptive immune systems. Our results demonstrate that in vivo genome editing with Cas9 RNPs has the potential for the local treatment for nongenetic degenerative diseases, expanding the scope of RNA-guided genome surgery to a new dimension. © 2017 Kim et al.-
dc.description.uri1-
dc.language영어-
dc.publisherCold Spring Harbor Laboratory Press-
dc.titleGenome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration-
dc.typeArticle-
dc.type.rimsART-
dc.identifier.wosid000395694000008-
dc.identifier.scopusid2-s2.0-85016448736-
dc.identifier.rimsid59311ko
dc.contributor.affiliatedAuthorKyoungmi Kim-
dc.contributor.affiliatedAuthorSeung Hwan Lee-
dc.contributor.affiliatedAuthorDaesik Kim-
dc.contributor.affiliatedAuthorTaeyoung Koo-
dc.contributor.affiliatedAuthorKwang-eun Kim-
dc.contributor.affiliatedAuthorJin-Soo Kim-
dc.identifier.doi10.1101/gr.219089.116-
dc.identifier.bibliographicCitationGENOME RESEARCH, v.27, no.3, pp.419 - 426-
dc.citation.titleGENOME RESEARCH-
dc.citation.volume27-
dc.citation.number3-
dc.citation.startPage419-
dc.citation.endPage426-
dc.description.journalClass1-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
Appears in Collections:
Center for Genome Engineering(유전체 교정 연구단) > 1. Journal Papers (저널논문)
Files in This Item:
Genome Res.-2017-Kim-gr.219089.116.pdfDownload

qrcode

  • facebook

    twitter

  • Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse